Annika Kasprzak

A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study

Giulia Maggioni, Matteo Bersanelli, Erica Travaglino et al. · The Lancet Haematology · 2022 · 34 citations · Full text

Medicine, Genetics, Hematology +16

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)

Annika Kasprzak, Kathrin Nachtkamp, Norbert Gattermann et al. · Cancers · 2022 · 16 citations · Full text

Medicine, Clinical Sciences, Hematology +13

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

Kathrin Nachtkamp, Corinna Strupp, M. Vukelja et al. · Leukemia · 2024 · 16 citations · Full text

Medicine, Hematology, Oncology +12

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies

Felicitas Schulz, Paul Jäger, Johanna Tischer et al. · Cancers · 2024 · 14 citations · Full text

Medicine, Immunology, Chemotherapy +14

Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes

Annika Kasprzak, Kathrin Nachtkamp, Mustafa Kondakci et al. · Annals of Hematology · 2020 · 10 citations · Full text

Medicine, Internal Medicine, Oncology +15